Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.12B |
| 2 |
Amazon
AMZN
|
+$606M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$542M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$409M |
| 5 |
Apple
AAPL
|
+$302M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.23B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.41B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$935M |
| 5 |
DuPont de Nemours
DD
|
+$669M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.63% |
| 2 | Financials | 5.94% |
| 3 | Consumer Discretionary | 5% |
| 4 | Communication Services | 4.96% |
| 5 | Healthcare | 4.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
CALL
Lam Research
LRCX
$369B
| $2.93M | ﹤0.01% |
62,000
| – | – |
|
1927
Range Resources
RRC
$9.43B
| $2.92M | ﹤0.01% |
436,572
-269,034
| -38% | -$1.98M |
|
1928
SouthState Bank Corp
SSB
$10.5B
| $2.91M | ﹤0.01% |
40,234
-17,395
| -30% | -$1.14M |
|
1929
PUT
VF Corp
VFC
$5.87B
| $2.9M | ﹤0.01% |
34,000
| – | – |
|
|
INN
1930
Summit Hotel Properties
INN
$749M
| $2.9M | ﹤0.01% |
321,938
-203,800
| -39% | -$1.51M |
|
|
ALE
1931
DELISTED
Allete
ALE
| $2.9M | ﹤0.01% |
46,789
+5,967
| +15% | +$338K |
|
|
CNST
1932
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $2.9M | ﹤0.01% |
100,573
-3,920
| -4% | -$98.7K |
|
1933
Artisan Partners
APAM
$2.99B
| $2.9M | ﹤0.01% |
57,507
-42,315
| -42% | -$1.92M |
|
1934
Monro
MNRO
$399M
| $2.89M | ﹤0.01% |
54,207
+4,429
| +9% | +$202K |
|
|
NXDT
1935
NexPoint Diversified Real Estate Trust
NXDT
$244M
| $2.89M | ﹤0.01% |
+166,651
| New | +$1.6M |
|
1936
Pitney Bowes
PBI
$2.48B
| $2.88M | ﹤0.01% |
468,401
+206,234
| +79% | +$1.24M |
|
|
LMNX
1937
DELISTED
Luminex Corp
LMNX
| $2.88M | ﹤0.01% |
124,479
-6,142
| -5% | -$143K |
|
1938
CALL
WIX.com
WIX
$2.38B
| $2.88M | ﹤0.01% |
11,500
| – | – |
|
|
BRSL
1939
Brightstar Lottery PLC
BRSL
$1.86B
| $2.87M | ﹤0.01% |
169,693
-175,562
| -51% | -$2.14M |
|
1940
Ligand Pharmaceuticals
LGND
$5.85B
| $2.86M | ﹤0.01% |
46,104
-29,806
| -39% | -$1.7M |
|
1941
Columbia Banking Systems
COLB
$8.91B
| $2.86M | ﹤0.01% |
79,567
-6,853
| -8% | -$212K |
|
1942
CVB Financial
CVBF
$4.03B
| $2.86M | ﹤0.01% |
146,452
-8,303
| -5% | -$157K |
|
1943
Brinker International
EAT
$9.66B
| $2.84M | ﹤0.01% |
50,277
-8,138
| -14% | -$402K |
|
|
UCB
1944
United Community Banks
UCB
$4.29B
| $2.84M | ﹤0.01% |
99,796
-1,422
| -1% | -$33.6K |
|
1945
HealthEquity
HQY
$8.72B
| $2.83M | ﹤0.01% |
40,663
-56,373
| -58% | -$3.51M |
|
1946
Bank OZK
OZK
$5.65B
| $2.83M | ﹤0.01% |
90,605
-136,462
| -60% | -$3.69M |
|
|
CADE
1947
DELISTED
Cadence Bancorporation
CADE
| $2.83M | ﹤0.01% |
172,508
-27,832
| -14% | -$369K |
|
1948
STAG Industrial
STAG
$7.44B
| $2.83M | ﹤0.01% |
90,397
-138,256
| -60% | -$4.32M |
|
1949
Regency Centers
REG
$14.7B
| $2.83M | ﹤0.01% |
62,042
+8,918
| +17% | +$384K |
|
1950
Vicor
VICR
$9.85B
| $2.83M | ﹤0.01% |
30,677
-2,501
| -8% | -$210K |
|
Similar funds
Barclays's Q4 2020 Portfolio in Review
As of Q4 2020, Barclays held 5,338 positions worth $189B, up 12% from $168B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays's Q4 2020 filing shows 130 new, 1,373 increased, 2,436 reduced and 454 closed positions. Its largest new stake was FTAI Aviation: 2,107,800 shares worth $42.2M. The largest sale was Visa, an estimated $2.23B.
By sector, the portfolio is most concentrated in Technology at 9.6% of assets, up from 8.9% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q4 2020 buy was FTAI Aviation: 2,107,800 shares worth $42.2M.
- Barclays added most to iShares US Real Estate ETF in Q4 2020, an estimated $1.12B increase.
- Barclays's biggest Q4 2020 reduction was Visa, cutting an estimated $2.23B.
- Barclays fully exited Noble Energy, Inc. in Q4 2020, selling an estimated $167M.
- Barclays's ten largest holdings make up 35% of its $189B portfolio in Q4 2020.
- Barclays opened 130 new positions and closed 454 in Q4 2020.
- Barclays's portfolio value rose 12% quarter-over-quarter to $189B.
Based on Barclays's 13F filing for Q4 2020, filed 11 Feb 2021.